Press Releases

Press Releases

Vaping is not a safe substitute for smoking and can damage the lungs—a case study of granulomatosis resulting from vaping

October 14, 2019 - Vaping is not a low-risk substitute for smoking cigarettes, according to researcher Charlie Lin, MD, who authored a case study of a 34-year-old former smoker diagnosed with granulomatosis attributed to two months of electronic cigarette use.

Pulmonary arterial hypertension treatment with macitentan is safe and effective for patients with systemic sclerosis

October 14, 2019 - Patients with pulmonary arterial hypertension (PAH) associated with systemic sclerosis (SSc) who were treated with macitentan had similar therapeutic and safety results as patients with PAH from both idiopathic PAH (IPAH) and heritable PAH (HPAH), which is caused by a genetic mutation that runs in families.

Further restricting blood transfusions guidelines could save lives and money

October 14, 2019 - Blood transfusion guidelines may require further evaluation with an eye to reducing transfusions for patients with stable blood pressure.

Combination drug therapy using macitentan and tadalafil for pulmonary arterial hypertension provides clear benefits

October 14, 2019 - Patients newly diagnosed with pulmonary arterial hypertension (PAH) treated with macitentan and tadalafil combination therapy showed hemodynamic progress, as well as improvements in function and risk profile.

Aclidinium is safe and reduces COPD flare-ups, regardless of recent exacerbations

October 14, 2019 - The long-acting bronchodilator aclidinium bromide (AB) is safe for patients at increased risk for heart attack and stroke and reduces the risk of new exacerbations in people with chronic obstructive pulmonary disease (COPD), regardless of whether they have had an exacerbation in the preceding year.

See all >